Markets.com Logo

CRMD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    13.7353$
  • Previous Close
    13.626$
  • 52 Week Change
    12.33$
  • Day Range
    0.11$
  • 52 Week High/Low
    5.1001$ - 17.43$
  • Dividend Per Share
    --
  • Market cap
    1 009 M$
  • EPS
    0.28
  • Beta
    1.71
  • Volume
    --

About

CRMD.US represents the stock of CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening infections and inflammatory diseases. Their lead product candidate, DefenCath/Neutrolin, is a catheter lock solution designed to prevent catheter-related bloodstream infections in hemodialysis patients. CorMedix is listed on the NYSE American exchange under the ticker symbol CRMD, and the .US extension commonly signifies that the stock is traded on a United States exchange. Investors can track the company's performance, access financial reports, and monitor news related to CorMedix Inc. using this ticker symbol.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

[Company Performance]: Financial results like revenue, earnings, and profitability directly impact investor confidence and stock price.

[Clinical Trial Results]: Success or failure in clinical trials for CRMD's drug candidates significantly influences stock valuation due to potential future revenue.

[Regulatory Approvals]: FDA or other regulatory body approvals for CRMD's drugs drive investor excitement and increase the stock price.

[Market Sentiment]: Overall market conditions and investor mood towards the pharmaceutical or biotechnology sector can affect CRMD's stock price.

[Competition]: The presence of competing drugs or treatments can impact CRMD's market share and, consequently, its stock price.

[Partnerships & Collaborations]: Forming strategic alliances or collaborations with other companies can increase investor confidence and boost the stock price.

[Management Team]: Changes in management or perception of leadership competence can influence investor sentiment and stock performance.

[Economic Factors]: Economic indicators such as interest rates, inflation, and economic growth can indirectly affect the stock market and CRMD's stock.

[Debt & Cash Flow]: Company's financial health, including its debt levels and cash flow, plays a vital role in determining its stock price.

[Analyst Ratings]: Stock analysts' ratings and price targets can influence investor decisions and cause fluctuations in CRMD's stock price.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--